Edico Genome

📍 San Diego, United States🗓 Founded 2013👥 15 employees💰 Last funded Jun 2014
Biotechnology🌐 edicogenome.com
Website LinkedIn
Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy. The “Big Data” Problem: As DNA sequencing costs have plummeted over the last few years, furthered by Illumina’s recent announcement of the ability to sequence genomes for below $1,000, raw data generated by sequencing has increased exponentially, measuring petabytes of data, making analyses and transfer of all this data difficult. These large amounts of data produce a critical bottleneck in the DNA sequencing workflow that has previously only been addressable by throwing increasing numbers of ever more powerful CPU cores at the problem. However, since the data being produced by sequencing already far outpaces Moore’s Law, this solution has very limited sustainability. DRAGEN™ Bio-IT Processor To address this problem, Edico Genome is developing the DRAGEN™ Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics reconfigurable processor. It enables the computational time required for the NGS data analysis pipeline to be radically reduced from many hours down to only a few minutes. The mapping, alignment, sorting and variant calling that is currently performed by software on extensive cluster or cloud-based platforms, is performed at a fraction of the computing cost by DRAGEN - without compromising accuracy. Our patent-pending technology makes it faster, easier and cheaper to work with NGS data and to discover links between DNA sequence variations and human disease.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2013–2014 · investors recorded per year
2013220141
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Edico Genome?
Edico Genome has 3 investors on record on gritt.io, including 3 early-stage backers.
When did Edico Genome last raise funding?
The most recent investment in Edico Genome recorded on gritt.io was in June 2014.
When was Edico Genome founded?
Edico Genome was founded in 2013.
What industry is Edico Genome in?
Edico Genome operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Edico Genome based?
Edico Genome is headquartered in San Diego, United States.